Showing posts with label asthma. Show all posts
Showing posts with label asthma. Show all posts

Thursday, April 25, 2013

Bitter taste receptors in the most unexpected places

Another in our very irregular series on unexpected biological function.  We've written before about spermatogenesis genes found in the brain, and vision-related opsins found in unseeing sea urchin spines.  Today it's bitter taste receptors in the airways -- and testis, and brain, and immune cells, and gastrointestinal tract.  And they may soon be harnessed for the treatment of asthma.  

More than 300 million people have asthma worldwide, a disease that is estimated to cause 1 in 250 deaths.  Prevalence has spiked in the last three decades, and it's still not clear why, though the hygiene hypothesis, the idea that we're too clean, which provokes our immune system to overreact, has gained traction.

There is a lot of variation in the disease -- some people have asthma with allergies, some with exercise, some with respiratory infections, people react differently to existing therapies, some are able to keep their disease well-controlled and others not, and so on.  Of course many genetic studies of asthma have been done, but to date no definitive genes with large effect have been identified. 

Like most complex diseases, it's likely that 'asthma' encompasses a variety of diseases, with a variety of causal circumstances, and again as with other diseases, this complicates the search for causes, both genetic and environmental, as well as treatments.  "Those of us who treat asthma know that it's very different in each person.  It's almost as if each person is an n of one," physician and asthma researcher Fernando Martinez told The Lancet in 2006, when the journal did a special issue on the disease.  In the same issue, the editors called for an end to the use of the word asthma entirely. 

This is all in line with the idea of personalized medicine, genomic or otherwise.  Treatment tailored to every individual.  But is it possible that all cases of asthma may have one thing in common that a single treatment could correct?

Asthma is characterized by wheeze, which happens when smooth muscle cells in the airways contract, causing narrowing of the airways and subsequent difficulty breathing.  Current therapies include bronchodilators, β2 adrenergic receptor agonists, that act on β2 adrenergic receptors to relax smooth muscle and cause airways to dilate.  They don't work for everyone, however, and can have adverse side effects. 

A paper recently published in PLoS Biology reports that smooth muscle in airways has bitter taste receptors, G-protein-coupled receptors, that trigger a cellular response.
Bitter taste receptors (TAS2Rs), a G-protein-coupled receptor family long thought to be solely expressed in taste buds on the tongue, have recently been detected in airways. Bitter substances can activate TAS2Rs in airway smooth muscle to cause greater bronchodilation than β2 adrenergic receptor agonists, the most commonly used bronchodilators. However, the mechanisms underlying this bronchodilation remain elusive. Here we show that, in resting primary airway smooth muscle cells, bitter tastants activate a TAS2R-dependent signaling pathway that results in an increase in intracellular calcium levels, albeit to a level much lower than that produced by bronchoconstrictors. In bronchoconstricted cells, however, bitter tastants reverse the bronchoconstrictor-induced increase in calcium levels, which leads to the relaxation of smooth muscle cells.
So, the search is on for bitter tastants that would be good candidates for a new and more effective class of bronchodilator.  By addressing a response that is characteristic of all asthma, constriction of the airway, this approach could be a much needed one-size-fits-all kind of drug, with fewer side effects than the current class of bronchodilators.

But why are bitter receptors in these unexpected places?  Olfactory receptors have also been found expressed in some tissues other than the nasal passageways, to the extent that someone once suggested that, in their diversity and uniqueness, they could be used body-wide as a kind of tissue-specific molecular 'area code'.  This doesn't seem likely, as there hasn't been much in that line of evidence for several years.

But these stories do show the diversity of gene functions and uses.  Do bitter taste receptors in the airways mean anything?  Have they got there by chance alone, with no historic nor adaptive function?  Could their presence there be a simple developmental side effect of their needing to be properly expressed in the tongue, which develops in nearby tissues in the embryo?  If so, why are they in the testis, and immune cells, suggesting they have multiple and diverse functions?

We've written many times about roadblocks to understanding. What we think we know too often blinds us to what we don't know.

Tuesday, January 15, 2013

Not to defend fast food, but does it really cause asthma?

Here's a case for confounding variables if there ever was one: a new study suggests that 'fast foods' cause asthma, rhinoconjunctivitis and eczema.  Indeed, the BBC tells us that teens who eat fast foods three or more times a week are 39% more likely to have severe asthma than kids who eat three or more servings of fruit each week. Sounds pretty clearly causal, doesn't it?  Well, maybe not.

The results are from a long-standing international study of asthma, begun in 1991 because of concern over increasing asthma rates.  Called ISAAC, the International Study of Asthma and Allergies in Childhood, the study is based in New Zealand but is associated with centers all over the world.  Asthma incidence began to rise in the mid 1980's and the trend has yet to be satisfactorily explained by environmental epidemiology.  And of course, many tens of millions of dollars have been spent looking for a genetic cause, without success.   

An ISAAC study published in 2004 reported that eating hamburgers was associated with increased risk.  Other studies have found some association with maternal diet during pregnancy, as well as childhood diet. 

Results from the latest paper relied on questionnaires translated into 53 languages, and included more than 500,000 children from 54 countries. Along with lifestyle questions, teenagers, and parents of younger children, were asked about symptoms of asthma, watery itchy eyes and eczema.  And, quoting from the paper, they were asked the following about their diet: ‘In the past 12 months, how often, on average, did you (did your child) eat or drink the following: meat; seafood; fruit; vegetables (green and root); pulses (peas, beans, lentils); cereal; pasta (including bread); rice; butter; margarine; nuts; potatoes; milk; eggs and fast food/burgers?’.  They could choose 'never or occasionally,' 'once or twice per week,' or ' ≥3 times per week.'

Covariates considered included exercise, television watching, maternal education, maternal smoking in the first year of life and current maternal smoking.

While the BBC story makes a case for fast food being the cause of asthma, rhinoconjunctivitis and eczema, the story is much less clear if you look at the details actually presented in the paper. In teenagers, fruits are 'protective' if eaten once or twice, or 3 or more times a week,
[m]ilk was inversely associated with current wheeze once or twice per week, severe asthma ≥3 times per week, VQ [current wheeze], current and severe rhinoconjunctivitis once or twice per week and current and severe eczema once or twice per week as well as ≥3 times per week for current eczema. Vegetable consumption was also inversely associated with current wheeze ≥3 times per week and VQ once or twice per week and ≥3 times per week.
So, milk was protective if consumed once or twice per week, but not if consumed three or more times per week.

'Risk factor foods' were butter, fast food, margarine and pasta ≥3 times per week.  And seafood was positively associated with 'severe asthma, current and severe rhinoconjunctivitis and current and severe eczema. Butter, margarine, nuts, pasta and pulses [legumes] were positively associated with one or more conditions.'  If there is some consistent causal factor -- dairy fat, say, why butter but not milk?  Why not eggs of meat, if it's just fat that's the risk factor?

In younger children (6-7),
For all centres combined, eggs, fruit, meat and milk ≥3 times per week were inversely associated with all three conditions, current and severe. Cereal ≥3 times per week was inversely associated with severe asthma. Vegetables once or twice per week and ≥3 times per week were inversely associated with current and severe wheeze as well as current and severe rhinoconjunctivitis and ≥3 times per week with current eczema.
So, eggs and meat are protective, whereas they aren't for older children (aged 13-14).  Indeed, risk factor food for younger children is fast food only.  And, the only food category both age groups have in common is fast food.  Which, of course, could include a large variety of things. 

To add to the difficulty making sense of these data, "there is considerable variation for some foods between centres within countries."  Indeed, take a look at the odds ratios (ORs), the measure of the strength of association between variables and outcome, for fruits and fast foods by age and country.  They are, by and large, all over the place.  So, the odds of having severe eczema if you eat fruit in Mexico, say, vs. never eating fruit are 0.15, or 2.0.  That is, risk ranges from much lower than never eating fruit, to twice as high. The odds of having current wheeze if you eat fruit in Spain are 0.50 or 2.0.  The overall data may well suggest a trend, but it's not one that is reliably evident center by center, or even within each country. 

So, apart from the question of why this story has been picked up by the media (well, we know why -- anything that indicts fast food has the potential to be sensational), how is it that these results can be all over the place like this?

For one thing, and we've said this numerous times in numerous posts, food questionnaires are notoriously unreliable.  Do you know how many times per week you consumed pasta in the past 12 months?  Or fruit? 

And, who is likely to eat more fast food?  Kids in cities.  Higher risk of asthma in cities has been documented over and over again.  It isn't clear why that is, though allergy to cockroaches has been suggested, or proximity to asthmagenic industry, although this contradicts the other widely held hypothesis that too much cleanliness is causal (this is the Hygiene Hypothesis, which we blogged about here), and kids on farms have frequently been found to be at lower risk of asthma, for whatever reason.  Ok, it's possible that fast food is the reason, but it's also possible (and we'd say likely) that it's a confounding variable, a factor that stands in for an actual but unknown and unmeasured risk factor that kids in cities are more exposed to than kids in rural areas.  We aren't saying that's so, just suggesting it's a possibility; whether this study shows this rural/urban disparity is not clear. 

The asthma epidemic is relatively recent.  Having fresh fruits and vegetables year-round is also relatively recent, so most grand and great-grandparents were disease-free for some other reason.  Unless, of course, fruit and veg are cancelling out the effect of fast foods in kids who eat both, which we can't tell from the report, but that does seem to be a rather contorted explanation, if so.

It is not our purpose to defend fast food here, but really, how unhealthy is it, relatively speaking?  Yes, it packs a lot of calories, and for a lot of people that's not a good thing, but what else might be wrong with fast food?  And we are talking about fast food as a whole -- Big Macs, fries, fish sandwiches, milk shakes; everything lumped into one.  The authors write, 'Biologically plausible mechanisms for the relationship between fast food consumption and asthma and allergic disease could be related to higher saturated fatty acids, trans fatty acids, sodium, carbohydrates and sugar levels of fast food and possibly preservatives.'  Maybe, but if so, what have fast foods got that bacon, beef, any desserts, and so on don't?

And, the authors suggest that fruits and vegetables are loaded with antioxidants, which are said to be protective -- against almost everything.  Except that multiple large double blind studies have found that they aren't.  So, again, it's possible that fruit and vegetable consumption is a proxy for some other unidentified protective factor.  Or not. 

Given that the data used in this study are recall data, the diseases self-reported, the causal reasoning purely speculative, and that there's a possible problem with multiple confounding variables, we're going to go out on a limb here and suggest that, based on this study, the diet/asthma-eczema-rhinoconjunctivitis connection is a tenuous one at best.

Monday, January 2, 2012

Those confounded links to the causes of asthma

We've blogged a number of times about asthma -- specifically, why has it increased in prevalence so dramatically over the last 30 years, and why hasn't epidemiology figured it out?  (Here's our most recent post on this, and here's one on the Hygiene Hypothesis.) A disease that goes from not so common to very common very quickly most likely has an environmental trigger.  It's unlikely to be some new genetic risk, because genes don't change that quickly, and it's likely to be an environmental cause with a major effect, since it's triggering the disease in a whole lot of people.  And, since epidemiology is best at figuring out major environmental effects -- smoking, infectious agents, um....  -- you'd think they'd have knocked this one long ago.  But no, the answer to why so many kids are getting asthma has been elusive.  Until maybe now.

But, let's back up.  Millions -- and millions -- of dollars have been spent on the genetics of asthma.  Numerous family studies, GWAS (genomewide association studies), admixture mapping studies, and so on, and nothing to explain any significant amount of variation in risk has yet been found.  The idea was -- we guess -- that while asthma was certainly increasing in prevalence, not everyone was getting it, and the explanation for that must be genetic.  Let's ignore the root cause, whatever had changed in the environment, and just explain why some people respond to whatever-it-is with asthma.  Beyond our current fetish with geneticizing everything that moves, the rationale was that druggable pathways would be identified this way, and so whether or not we understood the source of the epidemic, by golly, we would be able to sell a lot of drugs to treat it.

Ok, that's one approach.

But to be fair, environmental and observational epidemiologists did try their darndest to tease out the environmental cause, and all they got for their pains were confusing and contradictory results.  Breast feeding, bottle feeding; environments that were too clean or environments that were too dirty; lack of helminth infections, lack of air pollution (really -- this was based on observations such as that asthma was on the increase in the early days of the epidemic in places like West Germany, but not right over the wall in East Germany, where air pollution was high).  We got the Hygiene Hypothesis out of all this work, a still live conjecture about the importance of boosting our immune systems when we're young. Maybe true.

But now the asthma community has a new idea, and again to be fair, it's in part due to some good sleuthing by epidemiologists.  Actually, the idea isn't so new -- the first paper suggesting it was published in 1998 -- but the idea is just now getting legs.  It's probably the most likely possible solution to the question of what's causing this epidemic that has been offered to date.  (Though we're still disappointed that no one picked up on our suggestion in a 2006 paper that the use of plastic diapers grew right along with the asthma epidemic, a correlation that we thought might do with some looking into.) And if this current suggestion is true, it shows again the problem of correlation not proving causation.

A story in the New York Times reported on this recently. The idea is that acetaminophen causes asthma.  In the 1980's, when the epidemic began, doctors started recommending that parents treat their infants' pain and fever with acetaminophen rather than aspirin because aspirin had been found to cause Reyes' Syndrome.  So, Tylenol sales took off.  And, not too long after that, so did inhaler sales.  More than 20 studies that show this association have now been published, and it's starting to look strong, not only based on epidemiological measures such as the strength of the association (the strength of the association between air pollution and low risk was strong too, but more on that below), but with a fairly substantial understanding of the biological mechanism that could explain the risk.

Here's the abstract from a paper in the November issue of Pediatrics, by John McBride:
The epidemiologic association between acetaminophen use and asthma prevalence and severity in children and adults is well established. A variety of observations suggest that acetaminophen use has contributed to the recent increase in asthma prevalence in children: (1) the strength of the association; (2) the consistency of the association across age, geography, and culture; (3) the dose-response relationship; (4) the timing of increased acetaminophen use and the asthma epidemic; (5) the relationship between per-capita sales of acetaminophen and asthma prevalence across countries; (6) the results of a double-blind trial of ibuprofen and acetaminophen for treatment of fever in asthmatic children; and (7) the biologically plausible mechanism of glutathione depletion in airway mucosa. Until future studies document the safety of this drug, children with asthma or at risk for asthma should avoid the use of acetaminophen.
A somewhat more detailed description of the findings on JournalWatch is here.

So, some in the pediatric community are starting to take notice, and recommend that parents give their kids ibuprofen rather than acetaminophen or aspirin.  Though, some are still doubtful; parents give their children acetaminophen when they have fevers, often of viral origin, and it could be the virus that causes asthma, not the treatment, some say.  Others are dubious because many of the studies relied on parents recalling how much of the drug they gave their children sometimes years in the past.  Relying on recall is a common cause of iffy results in epidemiological studies.

In addition, according to the Times,
So far, only one randomized controlled trial has investigated the link. Researchers at Boston University School of Medicine randomly assigned 1,879 children with asthma to take either acetaminophen or ibuprofen if they developed a fever. The results, published in 2002, showed that children who took acetaminophen to treat a fever were more than twice as likely to seek a doctor’s care later for asthma symptoms as those who took ibuprofen.
Of course, these are children who already have asthma, which complicates the interpretation of causation, but it does suggest that the mechanism, glutathione depletion in airways, might indeed be involved (though see above).  What's really needed to confirm the role of acetaminophen is a prospective study of children from birth through childhood but the ethics of a study that involves giving acetaminophen to babies surely would be questionable at this stage.

So, what about these other associations that looked so strong not long ago?  The idea that helminth infections or air pollution might actually reduce risk of asthma?  They could still be true, it could be that asthma, which is as complex and variable a disease as almost any disease out there, could have many causes.  Or, if the acetaminophen link is true, then these other factors are either independent confounders or in some way actively interact with the acetaminophen-related mechanism.  In rural African villages where helminths are a common fact of life, or in cities where air pollution is high, acetaminophen use is not.  The Hygiene Hypothesis, even given that people have suggested possible biological explanations for it, may be on its way out.

If this association does explain the epidemic, there's still this question -- will geneticists stop looking for genes 'for' asthma?  We don't bet on it.  That's not to say that better treatment isn't needed, and that the triggers and responses need to be better understood because the biology is complex -- indeed, some say that every case is unique -- and asthma is often difficult to control.  But, continuing to search for genetic causation?  Bah, humbug.

Tuesday, November 29, 2011

Understanding pathways leads to drug discovery. Really?

One of the most often heard rationales for studying the genetics of disease is that increased understanding of gene pathways, or the products of gene pathways, will lead to new drug discoveries.  The idea is that even if mapping studies, like GWAS (see many of our earlier posts) don't discover 'the'  or 'blockbuster' genes 'for' a trait, they reveal genetic pathways in the biology of the trait that drugs can target.

However, while there have been some successes or hopeful trials, overall there is only limited evidence yet that this is as yet happening -- in fact, after a burst of initial enthusiasm for the new doors opened by the sequencing of the human genome, pharmaceutical companies have been cutting back on research and development, and few new drugs are currently in the pipeline -- drug discovery is risky, and payoffs are few.  This constriction of the new drug pipeline is why Francis Collins, director of the National Institutes of Health, has pushed "translational medicine" and NIH's involvement in drug development.

Well, as the special report on allergies in the Nov 24 issue of Nature notes, immunologists and allergists have long thought they understood what causes asthma, but the disease has increased dramatically in the last 3 decades or so, and new treatments are few and far between.  So much for the benefits of understanding pathway components. 
Since the discovery of immunoglobulin E (IgE) almost half a century ago, there has been a massive expansion in knowledge about how IgE antibodies work. Research has unravelled IgE's role in a myriad of cellular and molecular targets driving inflammatory responses and underlying complex allergic disorders. This knowledge might have been expected to lead to novel preventative and therapeutic pathways — unfortunately, this has not been the case.
The dramatic rise in allergy and asthma worldwide has increased the clinical need for treatment, but research focusing heavily on IgE as the main malefactor in allergies has not been translated into widespread patient benefit.
One problem, according to a piece by Stephen Holgate on why this is so, has been the pharmaceutical industry's reliance on animal models to both better understand the disease as well as to test new treatments.  But, humans are not mice.  In addition, allergic disease is complex, and involves not only biological pathways, but their interactions with environmental triggers as well as, presumably, an underlying genetic susceptibility.
Traditional therapy of allergic disease has in large part relied on the abatement of symptoms with H1-antihistamines (rhinoconjunctivitis, food allergy, urticaria), adrenaline (anaphylaxis) or β2–adrenoceptor agonists (asthma), and the suppression of inflammation with corticosteroids. Besides improving the pharmacology of known drugs, the only novel asthma therapies to emerge are leukotriene inhibitors (for example, montelukast) and the non-anaphylactogenic anti-IgE, omalizumab, both of which are directed at targets identified well over 40 years ago.
There have been disappointments with a wide range of biologics targeting activating receptors on T cells, cytokines, chemokines, adhesion molecules and inflammatory mediators. Having shown convincing efficacy in in-vitro cell systems and animal models, and possibly some level of efficacy in acute allergen challenge in mild asthma, all of these have fallen short of expectations when trialled in human asthma. In moderate–severe asthma, where the unmet therapeutic need is greatest, trials of novel biologics have revealed only small subgroups in which efficacy has been shown or is suggestive.
And, it has long been assumed that asthma is primarily an allergic response, but this is no longer thought to be so.  The idea now is that perhaps impaired innate immunity comes first, and leads to allergy.  So, much is known about allergies and asthma, but nowhere near enough.

The asthma question is one that highlights many of the current problems in epidemiology, genetics, and the understanding of causation.  Asthma prevalence has been climbing in the US and other industrialized countries since the 1980s.  Given its precipitous rise, it would seem that the problem is quintessentially one for environmental epidemiology, but even when looked at from that perspective, no convincing environmental cause has yet been identified, and in fact studies have produced a frustrating litany of contradictions -- it's cleanliness or dirt, breast feeding or bottle, this gene or that.  Yes, epidemiologists have turned to genetics to try to understand the disease, but clearly there's no genetic explanation for such a recent epidemic. 

Like most other common chronic conditions, asthma is a complex disease, with multiple causes and multiple pathways.  As Holgate concludes:
In the future, it is essential that asthma is not treated as a single disorder, but rather defined by causative pathways. We need new diagnostic biomarkers to identify patients most likely to respond to highly selective biologics, such as anti-IL-5 biologic (mepolizumab) and anti-IL-13 (lebrikizumab). These therapies are only active in particular subtypes of asthma, when the molecules they target lie on a causative disease pathway. 
Studies of large numbers of people with a common chronic disease like asthma, or heart disease or hypertension, are necessarily pooling cases with different causes, pathways, genetic backgrounds, and outcomes.  This limits the potential for successful findings.

Biological traits are the result of interactions among many different factors, genetic and otherwise.  Such interactions, and the way that evolution works, leads to redundancy, alternative pathways, overlapping pathways, and the like.  This was a major theme of our book The Mermaid's Tale.  Complexity is an easy word to say, and perhaps it's easy to use it to excuse failure to find blockbuster findings.  But the last couple of decades have systematically shown causal complexity to be real.

Besides complexity itself, a major problem is not simply that humans aren't mice.  It's also that we are all unique in our environmental exposures, genomics, and how our bodies respond.  Identifying single genes that may be involved in complex diseases, or even biophysiological pathways, may be a rationale for sticking with the genetic approach to understanding disease, but it's a far cry from prevention, treatment or cure.

Rather than promising simplistic causation and consequent intervention miracles, we feel that students and young investigators, and the funding mechanisms, should be geared towards coming to grips with complexity, rather than just spinning out ever more details.  Major practical, and we also believe conceptual challenges lie ahead.  Asthma is a good case in point.

Tuesday, February 8, 2011

Are we too clean? The hygiene hypothesis and asthma

Cleanliness is next to wheeziness?
An article in The New Yorker last week says that physicians have it all wrong when it comes to childhood allergies (also called atopy).  The recommendation of the American Pediatric Association since 2000 has been that, to prevent food allergies, infants should be breastfed exclusively for 6 months, with solid foods introduced one by one for the next 6 months, to monitor effects of each food, but avoiding eggs and peanuts, because they are the foods to which kids are most likely to develop allergies.

But peanut, egg and dairy allergies are now skyrocketing!  So, some people are starting to think that prevention by avoidance may actually be causing the disease and suggesting that perhaps infants should be exposed to these foods in small quantities much earlier than current recommendations.  And some studies are beginning to show that such exposure might in fact eliminate even an existing allergy.  Perhaps, according to the article, medicine has erred on the side of excessive cleanliness once again. Cleanliness reduces serious infectious disease exposures, perhaps, but one shouldn't overdo it because we've evolved to be commensal with microorganisms, both viruses and bacteria--we've coevolved with them, are absolutely covered inside and out with them, and in many ways our lives literally depend on them.

By the way, it's worth pointing out that while there is undoubtedly some genetic variation, overall genes have little if anything to do with the spike in allergy incidence--genomes haven't changed in the last 50 years! 

An inverse relationship between allergy and helminth infection has been recognized since the 1960s, despite the fact that both induce a similar immunological response, but the reasoning that allergy may be a side effect of excessive cleanliness starts with a hypothesis first proposed in 1989 in a paper published in the British Medical Journal in 1989.  This paper was the first to propose that the 'post industrial revolution epidemic' of hay fever and eczema in Britain could be due to what has come to be called the 'hygiene hypothesis'.  The author looked at a handful of factors that could be associated with risk of hay fever, in a study sample of 18,000 children. "Of the 16 perinatal, social, and environmental factors studied the most striking associations with hay fever were those for family size and position in the household in childhood."

The author concludes,
These observations do not support suggestions that viral infections, particularly of the respiratory tract, are important precipitants of the expression of atopy. They could, however, be explained if allergic diseases were prevented by infection in early childhood, transmitted by unhygienic contact with older siblings, or acquired prenatally from a mother infected by contact with her older children. Later infection or reinfection by younger siblings might confer additional protection against hay fever.  
Over the past century declining family size, improvements in household amenities, and higher standards of personal cleanliness have reduced the opportunity for cross infection in young families. This may have resulted in more widespread clinical expression of atopic disease, emerging earlier in wealthier people, as seems to have occurred for hay fever. 
The idea was soon fleshed out to suggest that reduced exposure to pathogens, such as hepatitis A, Toxoplasma gondii or helicobacter pylori, changes the balance between two types of immune response, type 1 (TH1, triggered by bacterial and viral infections and autoimmune diseases), and type 2 (TH2, associated with helminth infections and allergic diseases).  An extension of the hygiene hypothesis to include autoimmune diseases was proposed in 2002 (cited here), and has subsequently been demonstrated in animals.  E.g., in lab mice, the incidence of type 1 diabetes rises with cage cleanliness.  (Type 1 diabetes is another disease whose incidence has risen in the industrialized world, along with asthma.)


 A much-cited paper in Science in 2002 is worth quoting at length.
There has been a significant increase in the prevalence of allergic diseases over the past 2 to 3 decades. Currently, more than 130 million people suffer from asthma, and the numbers are increasing ; nevertheless, there is a considerably lower prevalence of allergic diseases in developing countries. There are also clear differences in the prevalence of allergies between rural and urban areas within one country. For example, in Ethiopia, asthma is more prevalent in urban areas than in rural villages, and asthma is more common in residents of urban Germany than in farmers living in rural Bavaria. To explain these observations, environmental factors associated with more industrialized and urban living have been studied intensively, but there is little consistent evidence to suggest that obvious risk factors, such as increased exposure to indoor allergens, pollution, or changes in diet and breastfeeding, could account for the rise in atopic diseases. However, another category of environmental factors, childhood infections, shows an overwhelming and consistent negative association with atopy and allergic diseases. Allergic sensitization is overrepresented among first-born but is less frequent in children from large families and those attending day care, suggesting that a frequent exchange of infections may have a protective effect. 


Divergent outcome of TH2 responses in industrialized (low pathogen exposure) and developing countries (high pathogen exposure). It has been argued that improved hygiene, frequent use of antibiotics, and vaccination has led to reduced bacterial and viral infections in industrialized countries and therefore to insufficient stimulation of TH1 responses, which in turn allows the expansion of TH2 cells. TH2 responses are characterized by increased IgE to allergens, mastocytosis, and eosinophilia. Mast cell degranulation and release of inflammatory mediators leads to mucus production and smooth muscle cell contraction, precipitating allergic diseases of the airways. Helminths are prevalent in developing countries and lead to strong TH2 responses. Nevertheless, helminth-infected populations show little signs of allergic disorders. This difference may be explained by the differences in exposure to pathogens. A high prevalence of chronic infections in developing countries results in persistent immune challenge, with cycles of infection and inflammation, which is followed by the triggering of anti-inflammatory molecules to restrict immunopathology. This dynamic interaction educates the immune system to establish a robust regulatory network, possibly the key to controlling allergic diseases. Such a network would be weakly developed in industrialized countries with a low pathogen load, allowing inappropriate immunopathological reactions to develop more readily.

As the worm turns!
The helminth connection led to some interesting work in the fine tradition of self-experimentation, with researchers infecting themselves with helminths and monitoring what happened to their own allergies or asthma, with some positive effect.  Some people now propose worm therapy, in fact, but the pathogen load has to be a heavy one.

But, as usual, the story is not so simple.  An article in last week's Scientific American discusses a paper in Pediatric Allergy and Immunology reporting that Ugandan kids of mothers treated for helminth infection when they were pregnant were more likely to have eczema than kids whose mothers weren't treated.  The paper is subscription only, so we don't have access to the full text, but it looks like the story is more complicated than Scientific American would have it.  Mothers were treated with 1 of 2 different anti-helminthic drugs (albendazole or praziquantel) or placebo, and, from what we can tell from the abstract, the effects seem to differ depending on which drug the mother received and which pathogens she was carrying.
Results:  Worms were detected in 68% of women before treatment. Doctor-diagnosed infantile eczema incidence was 10.4/100 infant years. Maternal albendazole treatment was associated with a significantly increased risk of eczema [Cox HR (95% CI), p: 1.82 (1.26–2.64), 0.002]; this effect was slightly stronger among infants whose mothers had no albendazole-susceptible worms than among infants whose mothers had such worms, although this difference was not statistically significant. Praziquantel showed no effect overall but was associated with increased risk among infants of mothers with Schistosoma mansoni [2.65 (1.16–6.08), interaction p = 0.02]. In a sample of infants, skin prick test reactivity and allergen-specific IgE were both associated with doctor-diagnosed eczema, indicating atopic aetiology. Albendazole was also strongly associated with reported recurrent wheeze [1.58 (1.13–2.22), 0.008]; praziquantel showed no effect.
It's impossible to know from the abstract whether the authors considered the alternative explanation, that any atopy and asthma was the result the drug of eliminating the infection, or in fact of the drug--as Holly pointed out here.

And, the same Science paper we've quoted at length suggests that TH1/ TH2 balance may not in fact be the explanation for the inverse correlation between helminth infection and allergy, but instead the protective effect of infection may have to do with the anti-inflammatory response it triggers.  Other severe infections such as measles or tuberculosis are also inversely correlated with allergy.  The authors propose an alternative protective pathway to explain the hygiene hypothesis:


Education of the immune system by pathogens. Dendritic cells can develop into distinct subpopulations, depending on the nature of the signals they receive from the microenvironment, and then direct T cell differentiation into polarized subsets. Viruses, bacteria, and helminths carry distinct signature molecules that interact with dendritic cells to stimulate TH1-type and TH2-type immune responses. When uncontrolled, strong TH1 and TH2 responses lead to autoimmunity and allergy. High pathogen burden may either change the physiology of the microenvironment or result in the accumulation of novel signature molecules that together endow dendritic cells with the ability to induce regulatory T cells. Regulatory T cells produce suppressory cytokines and are part of an anti-inflammatory network that ensures that inflammatory T cells (both TH1 and TH2) and their downstream effectors are kept under control.

So, does the 'hygiene hypothesis' explain the significant rise in asthma, allergies and autoimmune diseases in the industrialized world?  The evidence is building, but the relationship is still more of a correlation, based on epidemiological associations, than demonstrated causation and there are still many unanswered questions.  If nothing else, you can be sure that the complexity of the immune response, and how much is still not understood, are limiting factors when it comes to answering those questions.

But it is possible that one day the apparent protective mechanism will be demonstrated and understood, and therapeutic approaches will be designed based on this mechanism so you won't have to infect yourself with helminths to treat your asthma.

And, we'd like to point out that the mechanisms will involve genetic pathways, undoubtedly, and the approaches will involve molecular technology.  But the therapies won't depend on personalized medicine, nor on the sequencing of the human genome -- whose 10th anniversary is being so heavily feted this month in Science.

Tuesday, November 30, 2010

Is asthma 'catching'? Is everything? Who said we'd defeated infectious disease?

The incidence of childhood asthma skyrocketed through the 1980s and 1990s and no one knows why.  Environmental epidemiologists have attributed the cause to a wide variety of factors including breastfeeding, bottle feeding, absence of helminth infestation, dirt, excessive cleanliness, air quality (good or bad), presence of pets in the household in infancy, the absence of pets, the use of acetaminophen in infancy, and even Facebook -- note that many of these are directly contradictory.  A few studies early on found that kids who grow up on farms tend to be at lower risk of asthma, and this led to the "Hygiene Hypothesis" which posits essentially that an immune system without enough to do is an immune system that goes awry.


A trend in epidemiology in the last few decades, in direct response to the inability to definitively identify environmental causes of complex diseases such as asthma or heart disease or type 2 diabetes, has been to look inward instead, to look for genes 'for' these diseases.  This isn't surprising, given the promises made by the Human Genome Project, for example, that knowing the genome would allow us to explain the majority of disease.  And, in fairness, given the great successes of human genetics early on at finding single genes for rare largely pediatric diseases like cystic fibrosis or Tay Sachs, the idea that genes could explain other diseases (even most diseases) was highly appealing and seductive.

But this meant that diseases were geneticized that, in our opinion, should have been left to the environmental epidemiologists -- genes can't explain an epidemic that took off as fast as the asthma epidemic did because gene frequencies don't change nearly fast enough.  Even if you posit that those who are affected have a genetic susceptibility to whatever environmental factor is triggering the disease, still it's clear that something rapidly changed in the environment, and, for our money, research dollars should be going toward finding that rather than genes.  (Why epidemiology has such a hard time finding such factors is another story, but it's largely because the tools of the trade are best at finding risk factors with large effects, such as infectious agents.  Though, why that hasn't been true of asthma, which, given the nature of the spike in incidence, seems to have had a main effect cause, is perplexing.)

But, largely because of this failure, many genetic studies of asthma have been done in the last several decades, including large genomewide association studies (GWAS).  And, just as with other genetic studies of complex diseases, in what is a rather repetitive drumbeat for trait after trait, nothing major has been found to reliably explain this epidemic.  Sure, some genes have been reported, but they just don't explain enough to be the answer.  Now researchers still interested in the genetics of asthma are suggesting, as with other complex diseases, that there must be numerous interacting genes with small effect.  Which is much more likely than one or two causative genes, yes, but it doesn't answer the question of what caused the epidemic.

There have been many ideas about the environmental component, most of them having to do not with pathogens but with pollutants, a number of candidates being listed above.  But now Science reports in the 26 November issue that there may be a bacterial link with asthma.  Again, the 'more microbes is better' hypothesis:
As odd as this might sound, there's mounting evidence that bacteria matter. Babies born via cesarean section, who experience a more sterile entry into the world than those born vaginally, are more likely to get asthma. So are young children treated with many courses of antibiotics. Along with animal studies, these observations suggest that the balance of bacteria and other microbes help guide immune development—and that when the balance is disrupted, disease may follow.
But it's complex.
All of us play host to bacterial residents. But children who develop asthma, researchers are learning, are home to different bacteria—and sometimes a less diverse mix—than those who stay healthy. “It's really coming down to the bacterial community structure, who's there, and in what numbers, and where,” [University of Michigan immunologist] Huffnagle says. 
So far, the evidence linking asthma and bacteria are associations, not proof that an imbalance of bacteria causes the disease. The big question, says Martinez, is, “Do asthmatics have an immune system that makes them be colonized by different things? … Or is it because they were colonized by different things that caused them to have asthma?” 
Researchers are currently comparing the microbiome (the community of microbes that colonize an individual) of kids with asthma and kids without, kids on farms, and kids in cities, to try to answer this question.  This is another way to ask if it's genes or environment -- which came first, the microbes, or the host environment?  And, of course many kids born by C section don't get asthma, and many kids born vaginally do.  It's complex indeed.

Microbiome analysis has some merits, beyond being yet another genomic Golden Calf for research labs. But we can predict that it is yet again a hunt for needles in a needle-stack of complexity.  We're likely still to be left with the problem that as a complex phenotype, like all other complex phenotypes, asthma is hard to explain, and hard to define.  In fact, an editorial in The Lancet several years ago suggested that every case should be considered unique, causally, physiologically and in how it's treated.

It is interesting, however, that schools of public health  abandoned their infectious disease departments in the '70s, declaring effectively that we'd won that battle (cheered on,  naturally, by geneticists seeing themselves as the funding beneficiaries).  Now, not only are clearly infectious issues like HIV/AIDS, multiple antibiotic resistant TB, SARS, and various influenzas still plaguing us, along with resurgent malaria and other neglected tropical diseases.  But many GWAS 'hits' are landing in genes involved in the immune system.

Inflammatory bowel disease, Crohn's disease, macular degeneration, and even schizophrenia are in this category.  If these pan out (and the first ones seem clearly to have done so), it means that non-acute, sub-clinical infection of long duration may build into diseases that did not seem either contagious or infectious.  If that's so, and the message sinks in, then GWAS may have done a service.  And epidemiologists like the sometimes-fringy Paul Ewald who have been touting the role of infectious role in chronic disease will have been vindicated.